Your browser doesn't support javascript.
loading
Adjuvant aromatase inhibitor therapy and early markers for cardiovascular disease in breast cancer survivors.
van Ommen-Nijhof, Annemiek; Jacobse, Judy N; Steggink, Lars C; Lefrandt, Joop D; Gietema, Jourik A; van Leeuwen, Flora E; Schaapveld, Michael; Sonke, Gabe S.
Afiliação
  • van Ommen-Nijhof A; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. a.nijhof@nki.nl.
  • Jacobse JN; Department of Radiotherapy, Leiden University Medical Center, Leiden, The Netherlands.
  • Steggink LC; Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Lefrandt JD; Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands.
  • Gietema JA; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands.
  • van Leeuwen FE; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Schaapveld M; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Sonke GS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Breast Cancer Res Treat ; 196(3): 591-602, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36181605
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Doenças Cardiovasculares / Sobreviventes de Câncer Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Doenças Cardiovasculares / Sobreviventes de Câncer Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article